1-3 of 3
Raghuveer K. Ramachandra
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy

Pottayil G. Sasikumar, Raghuveer K. Ramachandra, Srinivas Adurthi, Amit A. Dhudashiya, Sureshkumar Vadlamani, Koteswararao Vemula, Sriharibabu Vunnum, Leena K. Satyam, Dodderi S. Samiulla, Krishnaprasad Subbarao, Rashmi Nair, Rajeev Shrimali, Nagaraj Gowda, Murali Ramachandra
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (6): 1081–1091.
https://doi.org/10.1158/1535-7163.MCT-18-0737
Published: 03 June 2019
View article titled, A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy
Open the PDF for A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy in another window
Includes: Supplementary data
Journal Articles

ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity

Tim H. Holmström, Anu-Maarit Moilanen, Tarja Ikonen, Mari L. Björkman, Tero Linnanen, Gerd Wohlfahrt, Stefan Karlsson, Riikka Oksala, Timo Korjamo, Susanta Samajdar, Srinivasan Rajagopalan, Shekar Chelur, Kishore Narayanan, Raghuveer K. Ramachandra, Jiju Mani, Rashmi Nair, Nagaraj Gowda, Thomas Anthony, Samiulla Dhodheri, Subhendu Mukherjee, Ravi K. Ujjinamatada, Nanduri Srinivas, Murali Ramachandra, Pekka J. Kallio
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (1): 28–38.
https://doi.org/10.1158/1535-7163.MCT-18-0204
Published: 02 January 2019
View article titled, ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity
Open the PDF for ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

Abstract B006: Functional antagonism of VSIG8-mediated immune suppression by oral VISTA agents

Pottayil G. Sasikumar, Sudarshan S. Naremaddepalli, Raghuveer K. Ramachandra, Nagesh Gowda, Manikyala Rao Yerramsetti, Srinivasa Rao Bandireddy, Sreenivas Adurthi, Jiju Mani, Rashmi Nair, Amit A. Dhudashia, Samiulla S. Dodheri, Nagaraj M. Gowda, Murali Ramachandra
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): B006.
https://doi.org/10.1158/1535-7163.TARG-17-B006
Published: 01 January 2018
View article titled, Abstract B006: Functional antagonism of VSIG8-mediated immune suppression by oral VISTA agents